Rheumatoid Arthritis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have signed the study's consent form, which has been approved by a Human Research Ethics Committee (HREC)
- People diagnosed with a non-inflammatory degenerative joint condition such as osteoarthritis or avascular necrosis (bone tissue death due to reduced blood supply), and/or rheumatoid arthritis
- People whose doctor has determined they are a suitable candidate for a first-time hip replacement surgery using implants that are fixed without bone cement
- People who have been fully informed about the study conditions and are willing to attend all required follow-up appointments for the duration of the study
Who may not be able to join:
- People who have an active infection, or a suspected hidden infection, in or around the hip joint at the time of the surgery
- People who have a mental health condition or a disorder affecting muscles or nerves that could create unsafe risks with the implant or make post-surgery care too difficult to manage
- People whose bone quality is too poor — due to disease, infection, or a previous implant — to properly support or hold the new hip implant in place
- People whose immune system is suppressed, or who have been taking steroid medications at higher-than-normal levels for more than 30 days
- People who need a revision hip replacement (a repeat surgery to fix or replace a previous hip implant) or a hip fusion procedure on the affected joint
- People who have a known allergy or sensitivity to the materials used in the study device
- People who are currently involved in an active Workers' Compensation investigation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gavin Clark, MD, Perth Hip and Knee
Phone: +61405307762
Australian sites
+61 8 64891777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
1 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Implant survivorship
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.